[6-K] Credicorp LTD Current Report (Foreign Issuer)

Rhea-AI Filing Summary

Jaguar Health, Inc. (NASDAQ: JAGX) received SEC notice that its Form S-3 shelf registration statement (File No. 333-288202) became effective on June 27, 2025 at 4:00 p.m. ET. The effectiveness allows the company to register and potentially issue securities in the future without additional SEC review, streamlining capital-raising activities. No financial terms, transaction details, or earnings information were disclosed in the notice.

Insights

Securities Analyst

TL;DR: Routine shelf S-3 effectiveness; neutral near-term impact.

The SEC EFFECT filing confirms Jaguar Health’s universal shelf registration is now active, giving management flexibility to issue equity, debt, or other securities when market conditions permit. While this can facilitate quicker fundraising, no immediate offering is announced, leaving dilution or leverage implications uncertain. Given the absence of deal size, pricing, or strategic context, the filing is largely administrative and does not materially alter the investment thesis at this stage.

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16 under the

Securities Exchange Act of 1934

For the month of June 2025

Commission File Number: 001-14014

CREDICORP LTD.

(Translation of registrant’s name into English)

Of our subsidiary

Banco de Credito del Peru:

Calle Centenario 156

La Molina 15026

Lima, Peru (Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

 Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____

 Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____

June 30, 2025

Securities and Exchange Commission - SEC

Re.: MATERIAL EVENT

Dear Sirs:

We hereby notify you as a Material Event that on June 27, 2025, our subsidiary Grupo Credito S.A. (“Grupo Credito”) has been notified of the following Tax Assessment Resolutions and Fine Resolutions (hereinafter, the “Resolutions”), with amounts expressed in Peruvian Soles (S/):

Concept		Number		Period		Concept		Amount (S/)		Interest (S/)		Total Amount (S/)
Tax Assessment Resolution		012-003-0146335		January 2018		Omitted Tax		551,802,763		494,619,443		1,046,422,206
Fine Resolution		012-002-0041144		January 2018		Fine		275,901,382		204,820,909		480,722,291
Tax Assessment Resolution		012-003-0146337		March 2018		Omitted Tax		15,122,812		13,192,688		28,315,500
Fine Resolution		012-002-0041145		March 2018		Fine		7,561,406		5,422,814		12,984,220
								850,388,363		718,055,854		1,568,444,217

Through these Resolutions, the Peruvian Tax Administration (Superintendencia Nacional de Aduanas y de Administración Tributaria – SUNAT) has determined that Grupo Credito should have withheld the Income Tax applicable to non-domiciled parties during two share purchase transactions conducted on the trading floor of the Lima Stock Exchange (Rueda de Bolsa de la Bolsa de Valores de Lima) involving shares issued by Banco de Credito del Peru. The transactions took place on May 7, 2018, for a total of 2.77% of the share capital, and on May 7, 2019, for a total of 0.9559% of the share capital, in which Grupo Credito acted as the buyer and Credicorp Ltd. as the seller. According to the tax authority, Grupo Credito is considered jointly liable for the aforementioned tax in its capacity as withholding agent.

According to information provided by Grupo Credito, the company will contest the Resolutions, as it considers them to be without legal foundation, arbitrary, and abusive. Consequently, Grupo Credito will assert the rights afforded to it by law.

The information in this Form 6-K (including any exhibit hereto) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.

Sincerely,

/s/ Guillermo Morales

Authorized Representative

Credicorp Ltd.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: June 30, 2025

	CREDICORP LTD. (Registrant)
	By:	/s/ Guillermo Morales
		Guillermo Morales
		Authorized Representative

FAQ

What did Jaguar Health (JAGX) announce in its EFFECT filing?

The SEC declared Jaguar Health’s Form S-3 shelf registration effective on June 27, 2025 at 4:00 p.m. ET.

Does the EFFECT filing mean Jaguar Health is issuing shares immediately?

No. The notice only confirms the shelf is active; no specific securities offering was announced.

Why is a Form S-3 effectiveness important for JAGX investors?

It streamlines future capital raises, allowing Jaguar Health to issue securities quickly when needed.

Were any financial terms or amounts disclosed in the EFFECT filing?

No financial amounts, pricing details, or transaction sizes were provided in the notice.

Could the shelf registration lead to dilution for existing JAGX shareholders?

Potentially, yes—if equity is issued under the shelf, shareholder dilution may occur, though no issuance is currently planned.